BioSpace News Archive

The COVID-19 pandemic has radically changed how Americans approach travel both domestic and international. Many people have questions about when they can safely travel again in the wake of the pandemic and what steps they can take to minimize the risk of contracting or spreading COVID-19 during their trip.

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, March 4, 2021.

Altasciences announced that they have acquired WCCT Global, Inc., an early stage clinical research organization, or CRO, located in Southern California on the U.S.A.’s West Coast.

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) is pleased to announce the appointment of Dr. Jay Noller to its Scientific Advisory Board.

Company Provides Updates on COVID-19 Vaccine Administration, Vaccine Equity Initiative Launch

Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been officially recognized as meeting all the requirements of ISO 13485; Medical Devices, Quality Management System Certification ensuring the consistent design, development, production, installation, and delivery for the Blood Volume Analyzer (BVA-100®) system is safe for its intended purpose.

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that Geoff Green, Chief Executive Officer of Longeveron, has been invited to give a presentation titled “A Regenerative Medicine Approach to Aging Frailty” at the Intercontinental Summit on Aging & Gerontology being held virtually on March 8, 2021

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report fourth quarter and full year 2020 financial results after the market close on Monday, March 1, 2021

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that Chugai Pharmaceutical Co., Ltd. has in-licensed the rights for AT-527 for the treatment of COVID-19 in Japan from Roche.

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is scheduled to participate and host investor meetings at the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021.